Skip to main content

Drug Interactions between Daptacel (DTaP) and olaparib

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

tetanus toxoid olaparib

Applies to: Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular) and olaparib

If you are currently being treated or have recently been treated with olaparib, you should let your doctor know before receiving tetanus toxoid. Depending on the dose and length of time you have been on olaparib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of olaparib therapy. If you have recently been vaccinated with tetanus toxoid, your doctor may choose to postpone treatment with olaparib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Moderate

diphtheria toxoid olaparib

Applies to: Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular) and olaparib

If you are currently being treated or have recently been treated with olaparib, you should let your doctor know before receiving diphtheria toxoid. Depending on the dose and length of time you have been on olaparib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of olaparib therapy. If you have recently been vaccinated with diphtheria toxoid, your doctor may choose to postpone treatment with olaparib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Moderate

pertussis, acellular olaparib

Applies to: Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular) and olaparib

If you are currently being treated or have recently been treated with olaparib, you should let your doctor know before receiving pertussis, acellular. Depending on the dose and length of time you have been on olaparib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of olaparib therapy. If you have recently been vaccinated with pertussis, acellular, your doctor may choose to postpone treatment with olaparib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Major

olaparib food

Applies to: olaparib

Do not consume grapefruit, grapefruit juice, or Seville oranges during treatment with olaparib. Doing so can significantly increase the blood levels of olaparib and increase the risk and/or severity of side effects such as nausea, vomiting, diarrhea, indigestion, loss of appetite, abdominal pain or discomfort, lung problems, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer